| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD6482 | GDSC1000 | pan-cancer | AAC | -0.077 | 0.03 |
| mRNA | N9-isopropylolomoucine | CTRPv2 | pan-cancer | AAC | 0.083 | 0.03 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | 0.1 | 0.03 |
| mRNA | HBX-41108 | CTRPv2 | pan-cancer | AAC | 0.097 | 0.03 |
| mRNA | XMD15-27 | GDSC1000 | pan-cancer | AAC | 0.082 | 0.03 |
| mRNA | KU-60019 | CTRPv2 | pan-cancer | AAC | 0.079 | 0.03 |
| mRNA | MS-275 | CTRPv2 | pan-cancer | AAC | 0.073 | 0.03 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | 0.11 | 0.03 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | 0.067 | 0.03 |
| mRNA | 3-Cl-AHPC | CTRPv2 | pan-cancer | AAC | 0.075 | 0.03 |